Medical News
-
-
Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
-
KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
-
Private Autopsies Give Arizona Families Answers After Nursing Home and Care Facility Deaths
-
Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
-
Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
-
Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
-
FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
-
Blue Sky Capital Strategies, LLC awarded Leasing and Financial Services agreement with Premier Inc
-
Addison Medical Opens New Primary Care Practice in Melbourne, Florida
-
Minus K Technology launches it Educational Giveaway for Universities and Colleges in the USA
-
DG Magnetics R&D LLC Announces Issuance of Second U.S. Patent, Expanding Its Electromagnetic Technology Portfolio
-
Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
-
Crossroads4Hope Announces The Lipschutz Women's Fund
-
DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
-
U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
-
Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
-
Marquis MD to Open Premium Concierge Medicine Company in Boca Raton, Florida
-
Business of Medicine: Essential Education for Healthcare Professionals
-
Florida Multiple Sclerosis Conference in Orlando on July 25, Brings MS Experts and 6.5 CME Credits
-
AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026